Optimal Solubility of Diclofenac β-Cyclodextrin in Combination with Local Anaesthetics for Mesotherapy Applications

Figure 3

Representative images of a turbid (a), a milky (b), and a limpid solution (c) as they show in the syringe. Components of each mixture are reported in brackets.

(a) Limpid solution: Akis 50 mg/mL + mepivacaine 2% (1 mL) + sodium bicarbonate (3 mL)

(b) Turbid solution: Akis 50 mg/mL + levobupivacaine 2.5 mg/mL (2 mL) + sodium bicarbonate (2 mL)

(c) Milky solution: Akis 50 mg/mL + levobupivacaine 2.5 mg/mL (2 mL) + normal saline (2 mL)